PBH
Price
$62.90
Change
+$0.18 (+0.29%)
Updated
Sep 26, 04:46 PM (EDT)
Capitalization
3.09B
34 days until earnings call
PRGO
Price
$21.34
Change
+$0.58 (+2.79%)
Updated
Sep 26, 04:55 PM (EDT)
Capitalization
2.86B
40 days until earnings call
Interact to see
Advertisement

PBH vs PRGO

Header iconPBH vs PRGO Comparison
Open Charts PBH vs PRGOBanner chart's image
Prestige Consumer Healthcare
Price$62.90
Change+$0.18 (+0.29%)
Volume$197
Capitalization3.09B
Perrigo
Price$21.34
Change+$0.58 (+2.79%)
Volume$10.32K
Capitalization2.86B
PBH vs PRGO Comparison Chart in %
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. PRGO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Buy and PRGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (PBH: $62.72 vs. PRGO: $20.76)
Brand notoriety: PBH and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PBH: 99% vs. PRGO: 150%
Market capitalization -- PBH: $3.09B vs. PRGO: $2.86B
PBH [@Pharmaceuticals: Generic] is valued at $3.09B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.86B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • PBH’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, PRGO is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 5 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • PBH’s TA Score: 5 bullish, 3 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBH is a better buy in the short-term than PRGO.

Price Growth

PBH (@Pharmaceuticals: Generic) experienced а -2.15% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -2.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.63%. For the same industry, the average monthly price growth was +25.30%, and the average quarterly price growth was +68.14%.

Reported Earning Dates

PBH is expected to report earnings on Oct 30, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.63% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.09B) has a higher market cap than PRGO($2.86B). PRGO has higher P/E ratio than PBH: PRGO (2827.00) vs PBH (14.72). PRGO YTD gains are higher at: -16.528 vs. PBH (-19.682). PRGO has higher annual earnings (EBITDA): 612M vs. PBH (362M). PRGO has more cash in the bank: 454M vs. PBH (140M). PBH has less debt than PRGO: PBH (1.04B) vs PRGO (3.65B). PRGO has higher revenues than PBH: PRGO (4.33B) vs PBH (1.12B).
PBHPRGOPBH / PRGO
Capitalization3.09B2.86B108%
EBITDA362M612M59%
Gain YTD-19.682-16.528119%
P/E Ratio14.722827.001%
Revenue1.12B4.33B26%
Total Cash140M454M31%
Total Debt1.04B3.65B29%
FUNDAMENTALS RATINGS
PBH vs PRGO: Fundamental Ratings
PBH
PRGO
OUTLOOK RATING
1..100
951
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
6392
PRICE GROWTH RATING
1..100
8486
P/E GROWTH RATING
1..100
662
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (84). This means that PRGO’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (100). This means that PBH’s stock grew somewhat faster than PRGO’s over the last 12 months.

PBH's SMR Rating (63) in the Pharmaceuticals Other industry is in the same range as PRGO (92). This means that PBH’s stock grew similarly to PRGO’s over the last 12 months.

PBH's Price Growth Rating (84) in the Pharmaceuticals Other industry is in the same range as PRGO (86). This means that PBH’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (66). This means that PRGO’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHPRGO
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 9 days ago
58%
Bullish Trend 3 days ago
61%
Declines
ODDS (%)
Bearish Trend 12 days ago
52%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWYIX61.76N/A
N/A
CIBC Atlas Equity Income Institutional
FACDX55.66N/A
N/A
Fidelity Advisor Health Care A
GFBLX40.61-0.22
-0.54%
American Funds Global Balanced F3
MVSSX32.31-0.26
-0.80%
Victory Integrity Small-Cap Value R6
JSVTX15.89-0.15
-0.94%
Janus Henderson Small-Mid Cap Value T

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.84%
PAHC - PBH
38%
Loosely correlated
-0.55%
PRGO - PBH
29%
Poorly correlated
-2.95%
AMPH - PBH
27%
Poorly correlated
-1.90%
AMRX - PBH
26%
Poorly correlated
-1.13%
APNHF - PBH
26%
Poorly correlated
N/A
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-2.95%
ORGO - PRGO
47%
Loosely correlated
-4.49%
EOLS - PRGO
44%
Loosely correlated
-1.81%
MLLNF - PRGO
43%
Loosely correlated
N/A
AMRX - PRGO
38%
Loosely correlated
-1.13%
ANIP - PRGO
33%
Loosely correlated
-1.71%
More